These results show a contradiction in the neuroprotective effects of metformin since, at the level of BBB, the AMPK activation favors the tight junctions and reduces the efflux of fluid to the interstitial space; but at the neuronal level, the acute AMPK activation during stroke has shown negative effects in these cells. The gene discussed is PRKAA2; the disease is Stroke.